<DOC>
	<DOCNO>NCT01138865</DOCNO>
	<brief_summary>CPAP , standard treatment Obstructive sleep apnea syndrome ( OSAS ) reduce sleep fragmentation neurocognitive deficit OSAS may also key role reduction cardiovascular , mortality risk patient .</brief_summary>
	<brief_title>Effect CPAP Biomarkers Patients With OSA</brief_title>
	<detailed_description>Obstructive sleep apnea ( OSA ) condition collapse upper airway sleep , result decrease complete cessation airflow . This lead repeat episode hypoxia sleep sleep fragmentation . It highly prevalent though under-recognized clinical problem.There increase evidence inflammation play important role development cardiovascular complication patient OSA . Continuous positive airway pressure ( CPAP ) standard treatment OSA significant symptoms.However , costly treatment option poor compliance important limit factor . CPAP treatment show improve daytime somnolence neurocognitive function people OSAS . However , effect cardiovascular biomarkers people OSAS satisfactorily assess . This study aim assess effect CPAP treatment cardiovascular biomarkers OSA .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>The 1st part study include 1. male female , age 3065 year , 2. AHI &gt; 5 excessive daytime sleepiness 3. na√Øve CPAP treatment . 4 . Subjects first part study moderately severe OSAS never receive treatment OSA , diabetes mellitus hypertension 1 . Hypothyroidism 2 . Chronic renal failure 3 . Chronic liver disease 4 . Chronic lung disease 5 . Known systemic inflammatory disease ( lupus , sarcoidosis connective tissue disorder ) , 6 . Use drug influence urinary protein excretion ( eg . steroid , lithium , NSAIDS , ACE inhibitors/Angiotensin Receptor Blockers etc . ) 7 . Immune deficiency condition 8 . Pregnancy 9 . Active menstruation time sample 10 . Macroalbuminuria ( aACR &gt; 300mg/g ) , 11 . Patients coronary artery disease leave ventricular dysfunction 12 . Not treatment hypertension , diabetes mellitus dyslipidemia 13 . Long lasting hypertension diabetes mellitus ( 5 year diagnosis )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>Cytokine level</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Albumin-creatinine ratio</keyword>
	<keyword>Continuous positive airway pressure ( CPAP )</keyword>
</DOC>